Investor Alert

New York Markets Open in:

Vertex Pharmaceuticals Inc.

NAS: VRTX

GO
/marketstate/country/us

Before the Bell

/zigman2/quotes/202259802/composite

$

186.64

Change

+0.97 +0.52%

Volume

Volume 73

Sep 21, 2021, 6:50 a.m.

Real time quotes

/zigman2/quotes/202259802/composite

Previous close

$ 185.67

$ 185.67

Change

-2.63 -1.40%

Day low

Day high

$185.07

$188.89

Open
Open: 186.89

52 week low

52 week high

$184.78

$280.99

Open

Market cap

$48.85B

Average volume

1.87M

P/E ratio

24.51

Rev. per Employee

$1.83M

EPS

7.57

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/vrtx

MarketWatch News on VRTX

  1. Vertex Pharmaceuticals Inc. stock falls Monday, still outperforms market

    5:29 p.m. Sept. 20, 2021

    - MarketWatch Automation

  2. Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market

    5:28 p.m. Sept. 15, 2021

    - MarketWatch Automation

  3. Vertex Pharmaceuticals Inc. stock falls Thursday, underperforms market

    5:29 p.m. Sept. 9, 2021

    - MarketWatch Automation

  4. Vertex Pharmaceuticals downgraded to hold from buy at Stifel Nicolaus

    6:28 a.m. Sept. 9, 2021

    - Tomi Kilgore

  5. Wall Street sees as much as 56% upside for its 20 favorite stocks

    7:01 a.m. Sept. 8, 2021

    - Philip van Doorn

  6. Vertex Pharmaceuticals downgraded to underweight from equal weight at Morgan Stanley

    10:44 a.m. Sept. 7, 2021

    - Tomi Kilgore

  7. Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market

    5:28 p.m. Sept. 3, 2021

    - MarketWatch Automation

  8. Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market

    5:29 p.m. Sept. 1, 2021

    - MarketWatch Automation

  9. Vertex Pharmaceuticals Inc. stock rises Tuesday, outperforms market

    5:28 p.m. Aug. 31, 2021

    - MarketWatch Automation

  10. Vertex Pharmaceuticals Inc. stock falls Monday, underperforms market

    5:29 p.m. Aug. 30, 2021

    - MarketWatch Automation

  11. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/vrtx

Other News on VRTX

  1. Is Now the Time to Ditch Pharma Stocks?

    11 min ago

    - Motley Fool

  2. 3 Winning Stocks Down 33% (or More) to Buy Hand Over Fist

    6:06 a.m. Sept. 19, 2021

    - Motley Fool

  3. Loomis Sayles Growth Portfolio Buys Vertex Pharmaceuticals Inc

    3:38 p.m. Sept. 17, 2021

    - GuruFocus.com

  4. Biogen (BIIB) Reports Mixed Data From Neuropathy Pain Study

    10:58 a.m. Sept. 17, 2021

    - Zacks.com

  5. Here's Why You Should Retain QIAGEN (QGEN) Stock For Now

    9:38 a.m. Sept. 16, 2021

    - Zacks.com

  6. 3 Explosive Biotech Stocks That Could 10X in 10 Years

    5:55 a.m. Sept. 16, 2021

    - Motley Fool

  7. Harding Loevner Global Equity Fund Q2 2021 Letter

    2:45 p.m. Sept. 15, 2021

    - Seeking Alpha

  8. 5 Reasons to Buy Vertex Pharmaceuticals (VRTX) Stock Now

    11:36 a.m. Sept. 15, 2021

    - Zacks.com

  9. Axsome's (AXSM) Migraine Drug AXS-07 NDA Gets FDA Acceptance

    10:26 a.m. Sept. 15, 2021

    - Zacks.com

  10. 3 Crash-Ready Stocks to Buy in September

    9:05 a.m. Sept. 14, 2021

    - Motley Fool

  11. Is QQQ Overvalued Or Undervalued?

    8:01 a.m. Sept. 14, 2021

    - Seeking Alpha

  12. 3 Nasdaq 100 Stocks Begging to Be Bought in September

    5:51 a.m. Sept. 14, 2021

    - Motley Fool

  13. 2 Top Biotech Stocks to Buy Right Now

    11:45 a.m. Sept. 11, 2021

    - Motley Fool

  14. Loading more headlines...
/news/pressrelease/company/us/vrtx

Press Releases on VRTX

  1. Vertex Reports Second-Quarter 2021 Financial Results

    4:01 p.m. July 29, 2021

    - BusinessWire - BZX

  2. S&P 500 Analyst Moves: VRTX

    11:48 a.m. July 22, 2021

    - MarketNewsVideo.com

  3. Vertex to Announce Second-Quarter 2021 Financial Results on July 29

    4:01 p.m. July 16, 2021

    - BusinessWire - BZX

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.